Skip to main content
Fuan Pharmaceutical （Group）co.,Ltd logo

Fuan Pharmaceutical （Group）co.,Ltd — Investor Relations & Filings

Ticker · 300194 ISIN · CNE1000011G4 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,013 across all filing types
Latest filing 2023-07-05 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300194

About Fuan Pharmaceutical （Group）co.,Ltd

https://www.fapharm.com

Fuan Pharmaceutical (Group) Co., Ltd. is an integrated pharmaceutical enterprise specializing in the research, development, production, and distribution of a wide range of chemical drugs. The company operates across the entire value chain, encompassing pharmaceutical intermediates, active pharmaceutical ingredients (APIs), and finished dosage forms. Its product portfolio primarily focuses on anti-infectives, particularly cephalosporins and penicillins, as well as treatments for cardiovascular diseases, oncology, and respiratory conditions. Fuan Pharmaceutical maintains large-scale manufacturing facilities and emphasizes technological innovation to support its diverse pipeline of generic and specialized medications. The group serves both domestic and international markets, providing essential healthcare solutions through its network of subsidiaries and specialized production bases.

Recent filings

Filing Released Lang Actions
关于收到尼麦角林化学原料药上市申请批准通知书的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement (694 characters) regarding the receipt of an approval notice from the National Medical Products Administration for the listing application of a chemical raw material drug. It contains no financial data, no detailed report, and no mention of financial results or management discussion. It is an official announcement about regulatory approval related to product listing, not a financial report or detailed filing. The document is not a report itself but an announcement of a regulatory event. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-07-05 Chinese
关于子公司收到富马酸喹硫平片药品注册证书的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement (694 characters) about a subsidiary receiving a drug registration certificate from a national regulatory authority. It does not contain financial data, management discussion, or detailed report content. It is an official announcement regarding regulatory approval related to the company's product line. There is no indication of financial results, board changes, or other report types. Given the short length and nature of the content, it fits best as a Regulatory Filing (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2023-06-29 Chinese
关于子公司收到瑞戈非尼上市申请批准通知书的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement (662 characters) regarding the approval notice received by a subsidiary for a drug listing application from a regulatory authority (国家药品监督管理局 - National Medical Products Administration). It provides details about the approval but does not contain financial data, management discussion, or detailed financial results. It is an official announcement about a regulatory approval event related to the company's product pipeline. It is not a full report, earnings release, or management report. Given the nature and length, it fits best as a Regulatory Filing (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2023-06-29 Chinese
关于子公司收到化学原料药上市申请批准通知书的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement (757 characters) from a company about its subsidiary receiving approval from the National Medical Products Administration for chemical raw material drug listing applications. It contains no financial data, no detailed financial statements, no management discussion, or regulatory certifications. It is an official announcement of a regulatory approval event related to product listing, not a financial report or management update. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or Management Reports. It is not a voting result, board change, or capital update. The document is a regulatory announcement about product approval, which fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other categories. Confidence is high due to clear content and short length indicating an announcement rather than a report.
2023-06-25 Chinese
关于子公司收到药品注册证书的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement (683 characters) regarding a subsidiary receiving a drug registration certificate from a national regulatory authority. It contains no financial data, no discussion of financial results, no management commentary, and no mention of shareholder votes or meetings. It is not a report or detailed presentation but a regulatory announcement about a product approval. The content fits best with a Regulatory Filings (RNS) classification, as it is a general regulatory announcement that does not fit other specific categories.
2023-06-19 Chinese
关于子公司收到药品注册证书的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement (623 characters) about a subsidiary receiving a drug registration certificate from the National Medical Products Administration. It contains no financial data, no detailed report, and no mention of financial results or management changes. It is an official announcement of a regulatory approval event related to the company's product line. The document is not a full report, earnings release, or management discussion. It fits best as a Regulatory Filing (RNS) because it is a general regulatory announcement that does not fit other specific categories.
2023-06-01 Chinese

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.